Cite

HARVARD Citation

    Hawton, A. et al. (2022). Measuring the cost-effectiveness of treatments for people with multiple sclerosis: Beyond quality-adjusted life-years. Multiple sclerosis. pp. 346-351. [Online]. 
  
Back to record